SENIOR MANAGEMENT

• Wayne Phillips CEO
• Market research UK
  INTERNATIONAL MARKET RESEARCH
  • Fabrice Allum: Board Director
  • Matthew Brooks: Director, Strategic MR
  • Anna Garofalo: Director, Strategic MR
  • Bridget Pumfrey: Director, Strategic MR
  • Sean Davies: Director, Strategic MR
  • Charlotte Savege: Director
  • Barry Crook: Director
  • Amanda Siebols: Research Consultant
• Market Research US
  INTERNATIONAL & US DOMESTIC
  MARKET RESEARCH
  • Jim Goldenberg: President
  • Thomas Hartford (T.H.) Kern: Senior Vice President, Strategic MR
  • Sally Davis: Senior Vice President,
    Strategic MR
    
  • Margie Sherr: Senior Vice President,
    Strategic MR
    
  • Andrea Stoltz: VP, Project Management
  • Rebekkah Carney: MIM VP, Medtech Market Research
  • Carolyn Ivins: Vice President
• Market Access and Consulting UK
  • Mike Mallinson: Managing Director
  • Shrinivas Rao Mukku: Lead Consultant, Global P&R
  • Robert White: Consultant
  • Enrico de Nigris: Consultant
  • Graeme Roberts: Consultant
  • Anna Gannedahl: Consultant
  • Henry Dummett: Consultant [Emerging Markets]
  • Ben Shankland: Consultant [Emerging Markets]
• Market Access and Consulting US
  • Michael Rizzo: Vice President
  • Caryn A. Zieses: Senior Consultant

Thomas Hartford (T.H.) Kern

SENIOR VICE PRESIDENT, STRATEGIC MARKETING RESEARCH

tkern@doublehelixdevelopment.com
Tel: 267 289 0310

T.H. has worked in the pharmaceutical market research arena since 1997. He joined double helix’s US team in summer 2006, previously working at GfK V2 as a Vice President and SBU leader.

T.H. specializes in designing and executing custom qualitative market research studies with a strategic focus. His firsthand experience includes a variety of qualitative and quantitative methodologies and study types, among them market needs assessments; product “war gaming,” positioning, repositioning, and messaging, as well as market landscape assessments and product in-licensing evaluations. T.H. has conducted focus groups and individual interviews with a broad array of professional and consumer audiences. He has conducted numerous KOL studies across a range of therapeutic areas including oncology, lipid disorders, infectious diseases, and managing chronic pain. TH earned BA and MA degrees in history from Johns Hopkins University in Baltimore, MD.